Elixir Pharmaceuticals : National Diabetes Advisory Board

April 09, 2008 - Elixir Pharmaceuticals, Inc., announced the formation of its U.S. Diabetes Advisory Board to provide independent scientific and clinical advice regarding the Company's product candidates in phase III development, Glinsuna™ (mitiglinide) and Metgluna™ (mitiglinide plus metformin), for the treatment of type 2 diabetes, as well as to provide input on other Elixir product candidates in development to treat metabolic diseases... [PDF] Elixir Pharmaceuticals' Press Release -